NDC 72789-164

LOSARTAN POTASSIUM50 mg 50 mg tablet, film coated

On the label: PD-Rx Pharmaceuticals, Inc.. It's repackaged: PD-Rx Pharmaceuticals, Inc. rebottles it from Strides Pharma Science Limited's NDC 64380-934.

Where the pills inside were made

Repackaging site

• PD-Rx Pharmaceuticals Inc., Oklahoma City, OK, United States · repackages it

Recalls

• Jun 26, 2023 · Class II · Strides Pharma Inc.
  Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
  Lots: Lot#: 7901903A, exp. date 04/2024
• Jun 6, 2022 · Class II · PD-Rx Pharmaceuticals, Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: Lots: D21C18 Exp. 09/30/22; E21A28 Exp. 09/30/22; E21C04 Exp. 09/30/22; E21D59 Exp. 09/30/22; G21B65 Exp. 09/30/22; H21A12 Exp. 09/30/22; H21D42 Exp. 09/30/22; K21D19 Exp. 10/31/22; A22A73 Exp. 10/31/22
• Jun 6, 2022 · Class II · PD-Rx Pharmaceuticals, Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: Lots: D21D63 Exp. 11/30/22; E21A73 Exp. 11/30/22; E21D35 Exp. 11/30/22; F21A28 Exp. 11/30/22; F21D04 Exp. 09/30/22; G21B03 Exp. 11/30/22; G21E23 Exp. 11/30/22; H21B46 Exp. 11/30/22; H21D46 Exp. 08/31/23; H21D46 Exp. 08/31/23; I21B67 Exp. 01/31/23; J21A26 Exp. 01/31/23; J21C44 Exp. 01/31/23
• Jun 6, 2022 · Class II · PD-Rx Pharmaceuticals, Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: Lots: G21C26 Exp. 07/31/22; H21B96 Exp. 07/31/22; I21B39 Exp. 07/31/22; I21C44 Exp. 07/31/22; D21F35 Exp. 10/31/22; E21A66 Exp. 10/31/22; E21C72 Exp. 10/31/22; E21F01 Exp. 10/31/22; F21C15 Exp. 10/31/22; F21E19 Exp. 10/31/22; G21B14 Exp. 10/31/22; K21A61 Exp. 11/30/22; L21A45 Exp. 11/30/22
• May 18, 2022 · Class II · Strides Pharma Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: NDC 64380-933-05 Lot 7901007A, Exp Date Jun-22; Lot 7901144A, 7901178A & 7901179A, Exp Date Sep-22; Lots 7901246A & 7901247A, Exp Date Oct-22; Lot 7901343A, Exp Date Dec-22. NDC 64380-933-08 Lot 7901006A, Exp Date Jun-22; Lot 7901145A & 7901180A, Exp Date Sep-22; Lot 7901181A, Exp Date Oct-22.
• May 18, 2022 · Class II · Strides Pharma Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: NDC 64380-934-05 Lot 7901146A, 7901147A, 7901148A & 7901149A, Exp Date Sep-22; Lot 7901279A, 7901280A, 7901281A, 7901282A, 7901283A & 7901284A, Exp Date Nov-22; Lot 7901359A, 7901360A & 7901361A, Exp Date Dec-22; Lot 7901362A, 7901406A, 7901407A, 7901408A & 7901409A, Exp Date Jan-23. 64380-934-0…
• May 18, 2022 · Class II · Strides Pharma Inc.
  CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
  Lots: 64380-935-05 Lots 7901047B, 7901048B, 7901049B & 7901050B, Exp Date Jul-22; Lots 7901185A, 7901186A, 7901187A & 7901188A, Exp Date Oct-22; Lots 7901250A, 7901251A & 7901252A, Exp Date Nov-22. 64380-935-08 Lots 7900813B, 7900814B, 7900908A, 7900935A, 7900936A, 7900937A, 7900938A & 7900939…

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Losartan: every company that makes it

Form

tablet, film coated, oral

Strength

50 mg

Approval

ANDA ANDA090382

On the market since

Oct 9, 2019

Package NDCs

72789-164-90

Official label

DailyMed (National Library of Medicine), updated Feb 16, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?